Area of research
Genetics · Infectious Diseases
Research interest
Research focused on Colonoscopy and Pioglitazone, with related work in Haploinsufficiency, HMGB1, Deep learning. Notable publications include 'The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the...', 'Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20', and 'HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway'.
Research trends and hotspots of metabolites and inflammatory bowel disease: a bibliometric analysis
Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis
Development and Validation of a Deep Neural Network for Accurate Identification of Endoscopic Images From Patients With Ulcerative Colitis and Crohn's Disease
Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20
Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice
HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway.
PubMed 2016cited by 54position: middle
The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway